These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20212187)

  • 1. The metabolic syndrome as a cluster of risk factors: is the whole greater than the sum of its parts?: comment on "The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis".
    Ding EL; Smit LA; Hu FB
    Arch Intern Med; 2010 Mar; 170(5):484-5. PubMed ID: 20212187
    [No Abstract]   [Full Text] [Related]  

  • 2. Continued popularity of metabolic syndrome as an entity and need for waist circumference measurement.
    Jain P
    Indian Heart J; 2007; 59(1):13-4. PubMed ID: 19098330
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic syndrome and its association with colorectal cancer: a review.
    Siddiqui AA
    Am J Med Sci; 2011 Mar; 341(3):227-31. PubMed ID: 20460980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypertriglyceridemic-waist phenotype is associated with the Framingham risk score and subclinical atherosclerosis in Canadian Cree.
    Poirier J; Kubow S; Noël M; Dupont C; Egeland GM
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):1050-5. PubMed ID: 26474723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic syndrome as a coronary risk factor. Prevention and treatment].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2003 Jul; 59(7):59-65. PubMed ID: 14560351
    [No Abstract]   [Full Text] [Related]  

  • 6. Independent metabolic syndrome variants predict new-onset coronary artery disease.
    Vaidya D; Mathias RA; Kral BG; Yanek LR; Becker LC; Becker DM
    Diabetes Care; 2010 Jun; 33(6):1376-8. PubMed ID: 20299483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity.
    Li Z; Deng ML; Tseng CH; Heber D
    Metab Syndr Relat Disord; 2013 Apr; 11(2):87-91. PubMed ID: 23259588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Syndrome X vs metabolic syndrome].
    Morales Villegas E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S173-88. PubMed ID: 17469345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erectile dysfunction. A predictor of metabolic syndrome?
    Craft BJ
    Adv Nurse Pract; 2008 Jan; 16(1):57-60. PubMed ID: 20014745
    [No Abstract]   [Full Text] [Related]  

  • 11. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From the metabolic syndrome to the concept of global cardiometabolic risk].
    Nádas J; Jermendy G
    Orv Hetil; 2009 May; 150(18):821-9. PubMed ID: 19383573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic risk factors associated with erosive esophagitis.
    Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.
    Zornitzki T; Ayzenberg O; Gandelman G; Vered S; Yaskil E; Faraggi D; Caspi A; Goland S; Shvez O; Schattner A; Knobler H
    QJM; 2007 Sep; 100(9):575-81. PubMed ID: 17693419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome components in the type 2 diabetic population who presented coronary artery disease.
    Bosevski M; Borozanov V; Gucev F; Bosevska G; Tosev S; Georgievska-Ismail Lj
    Prilozi; 2007 Dec; 28(2):161-9. PubMed ID: 18356787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin resistance syndrome and coronary artery disease.
    Kendall DM; Sobel BE; Coulston AM; Peters Harmel AL; McLean BK; Peragallo-Dittko V; Buse JB; Fonseca VA; Hill JO; Nesto RW; Sunyer FX;
    Coron Artery Dis; 2003 Jun; 14(4):335-48. PubMed ID: 12826934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome.
    Sucato V; Novo G; Evola S; Novo S
    Int J Cardiol; 2015; 186():96-7. PubMed ID: 25814352
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the International Diabetes Federation worldwide definition.
    Ezenwaka CE; Okoye O; Esonwune C; Onuoha P; Dioka C; Osuji C; Oguejiofor C; Meludu S
    Metab Syndr Relat Disord; 2014 Jun; 12(5):277-82. PubMed ID: 24601861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.